Cargando…

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer

Within triple negative breast cancer, several molecular subtypes have been identified, underlying the heterogeneity of such an aggressive disease. The basal-like subtype is characterized by mutations in the TP53 gene, and is associated with a low pathologic complete response rate following neoadjuva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Antonio, Liu, Yueying, Armeson, Kent, Park, Yeonhee, Ridinger, Maya, Erlander, Mark, Reuben, James, Britten, Carolyn, Kappler, Christiana, Yeh, Elizabeth, Ethier, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872222/ https://www.ncbi.nlm.nih.gov/pubmed/31751384 http://dx.doi.org/10.1371/journal.pone.0224420

Ejemplares similares

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters
por: Shin, Sol-Bi, et al.
Publicado: (2021)

Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy
por: Li, Zhenhua, et al.
Publicado: (2016)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022)

Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012)

Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
por: Song, Bing, et al.
Publicado: (2012)

Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1)
por: Colicino, Erica G., et al.
Publicado: (2018)

EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA
por: Valinciute, Gintvile, et al.
Publicado: (2021)

PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy
por: Ruf, Stefanie, et al.
Publicado: (2017)

Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination
por: Biswas, Ayan, et al.
Publicado: (2021)

Pericentriolar matrix (PCM) integrity relies on cenexin and polo-like kinase (PLK)1
por: Aljiboury, Abrar, et al.
Publicado: (2022)

Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
por: Valinciute, Gintvile, et al.
Publicado: (2023)

Hornerin mediates phosphorylation of the polo-box domain in Plk1 by Chk1 to induce death in mitosis
por: Song, Haiyu, et al.
Publicado: (2023)

Mechanisms Underlying Plk1 Polo-Box Domain-Mediated Biological Processes and Their Physiological Significance
por: Lee, Kyung S., et al.
Publicado: (2014)

Targeting Echinococcus multilocularis Stem Cells by Inhibition of the Polo-Like Kinase EmPlk1
por: Schubert, Andreas, et al.
Publicado: (2014)

Another string to the polo bow: a new mitotic role of PLK1 in centromere protection
por: Olukoga, Tomisin, et al.
Publicado: (2019)

A cryptic hydrophobic pocket in the polo-box domain of the polo-like kinase PLK1 regulates substrate recognition and mitotic chromosome segregation
por: Sharma, Pooja, et al.
Publicado: (2019)

Development and implementation of the SUM breast cancer cell line functional genomics knowledge base
por: Ethier, Stephen P., et al.
Publicado: (2020)

Polo-like kinase 1 (Plk1) regulates DNA replication origin firing and interacts with Rif1 in Xenopus
por: Ciardo, Diletta, et al.
Publicado: (2021)

Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1)
por: Liu-Sullivan, Nancy, et al.
Publicado: (2011)

The Centrosome-Specific Phosphorylation of Cnn by Polo/Plk1 Drives Cnn Scaffold Assembly and Centrosome Maturation
por: Conduit, Paul T., et al.
Publicado: (2014)

Centrioles generate a local pulse of Polo/PLK1 activity to initiate mitotic centrosome assembly
por: Wong, Siu‐Shing, et al.
Publicado: (2022)

STIL binding to Polo-box 3 of PLK4 regulates centriole duplication
por: Arquint, Christian, et al.
Publicado: (2015)

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells
por: Harris, Peter S, et al.
Publicado: (2012)

Mechanisms of nuclear pore complex disassembly by the mitotic Polo-like kinase 1 (PLK-1) in C. elegans embryos
por: Nkombo Nkoula, Sylvia, et al.
Publicado: (2023)

Caenorhabditis elegans polo-like kinase PLK-1 is required for merging parental genomes into a single nucleus
por: Rahman, Mohammad M., et al.
Publicado: (2015)

Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes
Publicado: (1996)

Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2017)

Polo-Like Kinase 1(PLK1) Immunohistochemical Expression in Triple Negative Breast Carcinoma: A Probable Therapeutic Target
por: Salama, Maha E, et al.
Publicado: (2021)

Polo-like kinase 1 (PLK1) O-GlcNAcylation is essential for dividing mammalian cells and inhibits uterine carcinoma
por: Yan, Sheng, et al.
Publicado: (2023)

Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cells
por: Raab, Monika, et al.
Publicado: (2019)

Computational Analysis of Phosphopeptide Binding to the Polo-Box Domain of the Mitotic Kinase PLK1 Using Molecular Dynamics Simulation
por: Huggins, David J., et al.
Publicado: (2010)

Involvement of Polo-like kinase 1 (Plk1) in quiescence regulation of cancer stem-like cells of the gastric cancer cell lines
por: Zhu, Lin, et al.
Publicado: (2017)

Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma
por: Sui, Xianxian, et al.
Publicado: (2020)

Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice
por: Ward, Alejandra, et al.
Publicado: (2011)

Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4(+) T cells ex vivo
por: Zhou, Dawei, et al.
Publicado: (2020)

Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
por: Shin, Sol-Bi, et al.
Publicado: (2020)

Polo-Like Kinase 1 (PLK1) Is Involved in Toll-like Receptor (TLR)-Mediated TNF-α Production in Monocytic THP-1 Cells
por: Hu, Jinyue, et al.
Publicado: (2013)

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome
por: King, Sharon I, et al.
Publicado: (2012)

Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni
por: Long, Thavy, et al.
Publicado: (2016)

Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB)
por: Bailey, Anders W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uvn0rjivocdlll1phgrucukk18